(Q34954039)

5 August 2017

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer (English)

1 reference

Sylvia Wassertheil-Smoller

5 August 2017

1 reference

4

object named as

Sylvia Wassertheil-Smoller

1 reference

5 August 2017

14

Judith Wylie-Rosett

1 reference

5 August 2017

17

Barbara V Howard

1 reference

5 August 2017

5

Joann E Manson

1 reference

5 August 2017

18

Howard D Strickler

1 reference

5 August 2017

Marc J Gunter

1

1 reference

5 August 2017

Donald R Hoover

2

1 reference

5 August 2017

Herbert Yu

3

1 reference

5 August 2017

Jixin Li

6

1 reference

5 August 2017

Tiffany G Harris

7

1 reference

5 August 2017

Thomas E Rohan

8

1 reference

5 August 2017

Xiaonan Xue

9

1 reference

5 August 2017

Gloria Y F Ho

10

1 reference

5 August 2017

Mark H Einstein

11

1 reference

5 August 2017

Robert C Kaplan

12

1 reference

5 August 2017

Robert D Burk

13

1 reference

5 August 2017

Michael N Pollak

15

1 reference

5 August 2017

Garnet Anderson

16

1 reference

5 August 2017

1 April 2008

1 reference

Cancer Epidemiology, Biomarkers & Prevention

5 August 2017

1 reference

5 August 2017

17

1 reference

5 August 2017

4

1 reference

5 August 2017

921-929

1 reference

Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Global cancer statistics, 2002

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Role of the insulin-like growth factor family in cancer development and progression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

C-Peptide Measurement: Methods and Clinical Utility

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Estrogen induces insulin-like growth factor-I expression in the rat uterus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Oestrogen regulated gene expression in normal and malignant endometrial tissue

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Endometrial cancer and the IGF system: a case-control study in Greece.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Fasting glucose is a risk factor for breast cancer: a prospective study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Overweight as an avoidable cause of cancer in Europe.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Association between Components of the Insulin-Like Growth Factor System and Endometrial Cancer Risk

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090086

Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol

9 December 2018

1 reference

12 December 2020

Hormonal regulation of expression of messenger RNA encoding insulin-like growth factor binding proteins in human endometrial stromal cells cultured in vitro

1 reference

12 December 2020

Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency

1 reference

12 December 2020

Insulin-like growth factor-I expression in normal and diseased endometrium

1 reference

12 December 2020

The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease

1 reference

12 December 2020

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period

1 reference

12 December 2020

Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men

1 reference

12 December 2020

Free insulin-like growth factor-I and breast cancer risk

1 reference

12 December 2020

10.1158/1055-9965.EPI-07-2686

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference